Axsome Therapeutics (AXSM) Share-based Compensation (QoQ) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Axsome Therapeutics | 11.82 Bn | 11.51 Bn | 176.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.11% |
| Dec 31, 2025 | -1.61% |
| Sep 30, 2025 | -6.13% |
| Jun 30, 2025 | 5.59% |
| Mar 31, 2025 | 6.01% |
| Dec 31, 2024 | 1.51% |
| Sep 30, 2024 | 1.30% |
| Jun 30, 2024 | 5.90% |
| Mar 31, 2024 | 6.74% |
| Dec 31, 2023 | 15.56% |
| Sep 30, 2023 | 2.80% |
| Jun 30, 2023 | 23.02% |
| Mar 31, 2023 | -65.67% |
| Dec 31, 2022 | 409,805.86% |
| Sep 30, 2022 | -9.50% |
| Jun 30, 2022 | 33.75% |
| Mar 31, 2022 | -99.87% |
| Dec 31, 2021 | 2.89% |
| Sep 30, 2021 | 4.93% |
| Jun 30, 2021 | 46.24% |
| Mar 31, 2021 | -33.44% |
| Dec 31, 2020 | 95.41% |
| Sep 30, 2020 | 120.68% |
| Jun 30, 2020 | -39.07% |
| Mar 31, 2020 | -24.18% |
| Dec 31, 2019 | 143.32% |
| Sep 30, 2019 | 30.15% |
| Jun 30, 2019 | -29.27% |
| Mar 31, 2019 | 255.81% |
| Dec 31, 2018 | -10.08% |
| Sep 30, 2018 | -17.27% |
| Jun 30, 2018 | -11.21% |
| Mar 31, 2018 | -0.44% |
| Dec 31, 2017 | 38.37% |
| Sep 30, 2017 | -19.76% |
| Jun 30, 2017 | -27.12% |
| Mar 31, 2017 | 52.65% |
| Dec 31, 2016 | -5.18% |
| Sep 30, 2016 | -4.89% |
| Jun 30, 2016 | -26.54% |
| Mar 31, 2016 | 259.83% |
| Dec 31, 2015 | -49.45% |
| Sep 30, 2015 | 94.56% |
| Jun 30, 2015 | 148.01% |